4.6 Article

Qualitative variation of anti-diabetic compounds in different tarragon (Artemisia dracunculus L.) cytotypes

Journal

FITOTERAPIA
Volume 82, Issue 7, Pages 1062-1074

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.fitote.2011.07.003

Keywords

Artemisia dracunculus; Wild tarragon; Polyploidy; Germplasm; Diabetes; Sakuranetin

Funding

  1. National Center for Complementary and Alternative Medicine (NCCAM) [P50AT002776-01]
  2. Office of Dietary Supplements (ODS)
  3. Botanical Research Center of Pennington Biomedical Research Center
  4. Biotech Center of Rutgers University
  5. Fogarty International Center [U01TW006674]
  6. Rutgers University Graduate School
  7. C. Reed Funk Plant Biology Student Fund

Ask authors/readers for more resources

Ethanolic extracts of diploid Artemisia dracunculus L (wild tarragon) from populations in the U.S., and polyploid tarragon from a variety of sources, were screened for the anti-diabetic compounds davidigenin; sakuranetin; 2',4'-dihydroxy-4-methoxydihydrochalcone; 4,5-di-O-caffeoylquinic acid; 5-O-caffeoylquinic acid and 6-demethoxycapillarisin using LC-MS. Only decaploid plants contained all six target compounds and were the only plants that contained davidigenin and 2,4-dihydroxy-4-methoxydihydrochalcone. These results exhibit the importance of germplasm selection and provenance when studying plants for medicinal activity. Relying only on the right species for consistent medicinal activities may not be sufficient, as intraspecific variation may be highly significant. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available